SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

Search

Fagron

Închisă

SectorSănătate

19.26 0.52

Rezumat

Modificarea prețului

24h

Curent

Minim

18.86

Maxim

19.3

Indicatori cheie

By Trading Economics

Venit

-298K

40M

Vânzări

13M

443M

P/E

Medie Sector

17.346

63.778

Randament dividend

1.58

Marjă de profit

9.066

Angajați

3,828

EBITDA

-4.3M

71M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+20.59% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.58%

2.39%

Statistici piață

By TradingEconomics

Capitalizare de piață

19M

1.4B

Deschiderea anterioară

18.74

Închiderea anterioară

19.26

Fagron Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 apr. 2025, 23:04 UTC

Top știri

JPMorgan Raises Risk of U.S., Global Recession to 60%

3 apr. 2025, 22:40 UTC

Principalele dinamici ale pieței

Aldeyra Shares Fall on FDA Complete Response Letter for Dry Eye Disease Drug

3 apr. 2025, 22:18 UTC

Achiziții, Fuziuni, Preluări

Quantum Corp. Gets Strategic Investment, Names New Financial Chief

3 apr. 2025, 18:51 UTC

Achiziții, Fuziuni, Preluări

Capital One, Discover Merger Clears Regulatory Hurdle, Sources Tell The New York Times

3 apr. 2025, 23:43 UTC

Market Talk

Gold Steady, Supported by Potential Safe-Haven Demand -- Market Talk

3 apr. 2025, 23:41 UTC

Market Talk

Nikkei May Fall as U.S. Tariffs Raise Concerns About Global Growth -- Market Talk

3 apr. 2025, 22:22 UTC

Achiziții, Fuziuni, Preluări

Is TikTok Getting Banned? What to Expect as the Deadline Approaches. -- Barrons.com

3 apr. 2025, 22:21 UTC

Achiziții, Fuziuni, Preluări

Is TikTok Getting Banned? What to Expect as the Deadline Approaches. -- Barrons.com

3 apr. 2025, 21:43 UTC

Top știri
Câștiguri

The Day Trump's Tariffs Shook Wall Street and Corporate America -- 5th Update

3 apr. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

3 apr. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 apr. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 apr. 2025, 20:43 UTC

Market Talk

Plummeting Toronto Home Sales Reflect Trade, Political Uncertainty -- Market Talk

3 apr. 2025, 20:34 UTC

Top știri

Trump's Tariffs Were Supposed to Boost the Dollar, But Here's Why the Opposite Happened -- Heard on the Street -- 2nd Update

3 apr. 2025, 20:23 UTC

Top știri

Trump Tariffs Send Dow Industrials to 1600-Point Decline; Dollar Slumps -- WSJ

3 apr. 2025, 20:15 UTC

Achiziții, Fuziuni, Preluări

Blackstone Life Sciences And Anthos Therapeutics Announce Novartis Has Completed The Acquisition Of Anthos Therapeutics In A Deal Valued At Up To $3.1B, With $925M Paid Upfront >BX

3 apr. 2025, 19:55 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 apr. 2025, 19:55 UTC

Market Talk

Dollar Weakens as Investors Seek Safety Elsewhere -- Market Talk

3 apr. 2025, 19:21 UTC

Market Talk

Oil Futures Slide on U.S. Tariffs, OPEC+ Output Plan -- Market Talk

3 apr. 2025, 19:15 UTC

Market Talk

U.S. Natural Gas Stays Focused on Weather, Storage -- Market Talk

3 apr. 2025, 18:45 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

3 apr. 2025, 18:45 UTC

Market Talk

Gold Drops In Tariff Fallout -- Market Talk

3 apr. 2025, 18:39 UTC

Market Talk

U.S. Tariffs Could Give Natural Gas Edge Over Solar -- Market Talk

3 apr. 2025, 18:38 UTC

Top știri

Trump Tariffs Send Dow Industrials to 1400-Point Decline; Dollar Slumps -- WSJ

3 apr. 2025, 18:30 UTC

Top știri

Auto Industry Braces for Major Pain From Trump's Tariffs -- Analysis

3 apr. 2025, 18:20 UTC

Market Talk

Uncertainty Still Roils Companies in Tariff Saga -- Market Talk

3 apr. 2025, 18:18 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

3 apr. 2025, 18:17 UTC

Market Talk

U.S. Workers Can't Match International Labor as Companies Consider Moving Supply Chains -- Market Talk

3 apr. 2025, 18:04 UTC

Market Talk

US Sees More Job Openings in Construction, Transportation -- Market Talk

3 apr. 2025, 17:55 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

Fagron Așteptări

Obiectiv de preț

By TipRanks

20.59% sus

Prognoză pe 12 luni

Medie 19.5 EUR  20.59%

Maxim 19.5 EUR

Minim 19.5 EUR

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruFagron - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Fagron

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.